These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8200078)

  • 81. Tumor and serum tamoxifen concentrations in the athymic nude mouse.
    DeGregorio MW; Coronado E; Osborne CK
    Cancer Chemother Pharmacol; 1989; 23(2):68-70. PubMed ID: 2910513
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Effects of pentachlorophenol on the levels of hepatic glycogen].
    Nishimura H; Nishimura N; Oshima H
    Sangyo Igaku; 1982 Jul; 24(4):398-9. PubMed ID: 7143812
    [No Abstract]   [Full Text] [Related]  

  • 83. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Evidence from 32P-postlabeling and the use of pentachlorophenol for a novel metabolic activation pathway of diethylstilbestrol and its dimethyl ether in mouse live: likely alpha-hydroxylation of ethyl group(s) followed by sulfate conjugation.
    Moorthy B; Liehr J; Randerath E; Randerath K
    Carcinogenesis; 1995 Nov; 16(11):2643-8. PubMed ID: 7586180
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pentachlorophenol enhances 9-hydroxybenzo [a] pyrene-induced hepatic DNA adduct formation in vivo and inhibits microsomal epoxide hydrolase and glutathione S-transferase activities in vitro: likely inhibition of epoxide detoxication by pentachlorophenol.
    Moorthy B; Randerath K
    Arch Toxicol; 1996; 70(11):696-703. PubMed ID: 8896715
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tamoxifen-DNA adduct formation in rat liver determined by immunoassay and 32P-postlabeling.
    Divi RL; Osborne MR; Hewer A; Phillips DH; Poirier MC
    Cancer Res; 1999 Oct; 59(19):4829-33. PubMed ID: 10519392
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans.
    White IN
    Curr Drug Metab; 2003 Jun; 4(3):223-39. PubMed ID: 12769667
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Strong intensification of mouse hepatic tamoxifen DNA adduct formation by pretreatment with the sulfotransferase inhibitor and ubiquitous environmental pollutant pentachlorophenol.
    Randerath K; Bi J; Mabon N; Sriram P; Moorthy B
    Carcinogenesis; 1994 May; 15(5):797-800. PubMed ID: 8200078
    [TBL] [Abstract][Full Text] [Related]  

  • 89.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 90.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 91.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 92.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 93.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.